Transforming growth factor-β: Possible roles in carcinogenesis

British Journal of Cancer

Volumn 57, Issue 6, 1988, Pages 594-600

  Roberts, A B ^a   Thompson, N L ^a   Heine, U ^b   Flanders, C ^a   Sporn, M B ^a  

^a Laboratory of Chemoprevention   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CARCINOGENESIS; HISTOLOGY; HUMAN; NONHUMAN; REVIEW;

ANIMAL; CHEMISTRY; EMBRYO AND FETAL DEVELOPMENT; MICE; NEOPLASMS; PEPTIDES; TRANSFORMING GROWTH FACTORS;

EID: 0023925274     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.135     Document Type: Article

References (78)

1. ALLEN, J.B., MALONE, D.G., WAHL, S.M., CALANDRA, G.B. & WILDER, R.L. (1985). Role of the thymus in streptococcal cell wall induced arthritis and hepatic granuloma formation. J. Clin. Invest., 76, 1042.
2. ANZANO, M.A., ROBERTS, A.B., SMITH, J.M., SPORN, M.B. & DE LARCO, J.E. (1983). Sarcoma growth factor from conditioned medium is composed of both type alpha and type f transforming growth factors. Proc. Natl Acad. Sci., USA, 80, 6264.
3. ANZANO, M.A., ROBERTS, A.B., DE LARCO, J.E. & 6 others (1985). Increased secretion of type, B transforming growth factor accompanies viral transformation of cells. Mol. Cell. Biol., 5, 242.
4. ANZANO, M.A., ROBERTS, A.B. & SPORN, M.B. (1986). Anchorageindependent growth of primary rat embryo cells is induced by platelet-derived growth factor and inhibited by type-, B transforming growth factor. J. Cell. Physiol., 126, 312.
5. ASSOIAN, R.K., FLERUDELYS, B.E., STEVENSON, H.C. & 5 others (1987). Expression and secretion of type fl transforming growth factor by activated human macrophages. Proc. Natl Acad. Sci. USA, 84, 6020.
6. ASSOIAN, R.K., GROTENDORST, G.R., MILLER, D.M. & SPORN, M.B. (1984). Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature, 309, 804.
7. ASSOIAN, R.K., KOMORIYA, A., MEYERS, C.A., MILLER, D.M. & SPORN, M.B. (1983). Transforming growth factor-# in human platelets. J. Biol. Chem., 258, 7155.
8. ASSOIAN, R.K. & SPORN, M.B. (1986). Type-fl transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol., 102, 1217.
9. BAIRD, A. & DURKIN, T. (1986). Inhibition of endothelial cell proliferation by type-fl transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Comm., 138, 476.
10. BOWEN-POPE, D.F., VOGEL, A. & ROSS, R. (1984). Production of platelet-derived growth factor molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc. Natl Acad. Sci. USA, 81, 2396.
11. CATE, R.L., MATTALIANO, R.J., HESSION, C., TIZARD, R. & 15 others 1986. Isolation of the bovine and human genes for miullerian inhibiting substance and expression of the human gene in animal cells. Cell, 45, 385.
12. CENTRELLA, M., MCCARTHY, T.L. & CANALIS, E. (1987). Mitogenesis in fetal rat bone cells simultaneously exposed to type, B transforming growth factor and other growth regulators. FASEB J., 1, 312.
13. CHEIFETZ, S., WEATHERBEE, J.A., TSANG, M.L.-S., & 4 others (1987). The transforming growth factor-, B system, a complex pattern of cross-reeactive ligands and receptors. Cell, 48, 409.
14. CHIANG, C.-P. & NILSEN-HAMILTON, M. (1986). Opposite and selective effects of epidermal growth factor and human platelet transforming growth factor-, B on the production of secreted proteins by murine 3T3 cells and human fibroblasts. J. Biol. Chem., 261, 10478.
15. COFFEY, R.J., GOUSTIN, A.S., SODERQUIST, A.M. & 4 others (1987). Transforming growth factor-alpha and, B expression in human colon cancer lines: Implications for an autocrine model. Cancer Res., 47, 4590.
16. CONNOR, T.B., ROBERTS, A.B., SPORN, M.B. & 6 others (1988). Correlation of fibrosis and transforming growth factor-fl type 2 levels in the eye. New Engl. J. Med. (submitted).
17. CUTTITA, F., CARNEY, D.N., MULSHINE, J. & 4 others (1985). Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature, 316, 823.
18. DANIELPOUR, D., DART, L.L., FLANDERS, K.C., ROBERTS, A.B. & SPORN, M.B. (1986). Autocrine inhibition of mink lung epithelial growth by TGF-fl2. J. Cell. Biochem. Suppl. (in press).
19. DE MARTIN, R., HAENDLER, B., HOFER-WARBINEK, R., & 7 others (1987). Complementary DNA for human glioblastoma-derived T cell suppresor factor, a novel member of the transforming growth factor-fl gene family. EMBO J., 6, 3673.
20. DERYNCK, R., GOEDEL, D.V., ULRICH, A., & 4 others (1987). Synthesis of messenger RNAs for transforming growth factors alpha and, B and the epidermal growth factor receptor by human tumors. Cancer Res., 47, 707.
21. DERYNCK, R., JARRETT, J.A., CHEN, E.Y. & 6 others (1985). Human transforming growth factor-fl cDNA sequence and expression in tumor cell lines. Nature, 316, 701.
22. DVORAK, H.F. (1986). Tumors: Wounds that do not heal. New Engl. J. Med., 315, 1650.
23. EDWARDS, D.R., MURPHY, G., REYNOLDS, J.J. & 4 others (1987). Transforming growth factor, B modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J., 6, 1899.
24. ELLINGSWORTH, L.R., BRENNAN, J.E., FOK, K. & 4 others (1986). Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor, B. J. Biol. Chem., 261, 12362.
25. FROLIK, C.A., DART, L.L., MEYERS, C.A., SMITH, D.M. & SPORN, M.B. (1983). Purification and initial characterization of a type f, transforming growth factor from human placenta. Proc. Natl Acad. Sci. USA, 80, 3676.
26. HADDOW, A. (1972). Molecular repair, wound healing, and carcinogenesis: Tumour production a possible overhealing? Adv. Cancer Res., 16, 181.
27. HAY, E.D. (1981). Collagen and embryonic development. In Cell Biology of Extracellular Matrix, Hay, E.D. (ed). p. 379. Plenum Press: New York.
28. HEINE, U.I., MUNOZ, E.F., FLANDERS, K.C. & 5 others (1987). Role of transforming growth factor-fl in the development of the mouse embryo. J. Cell. Biol., 105, 2861.
29. HILL, D.J., STRAIN, A.J., ELSTOW, S.F., SWENNE, I. & MILNER, R.D.G. (1986a). Bi-functional action of transforming growth factor-f on DNA synthesis in early passage human fetal fibroblasts. J. Cell. Physiol., 128, 322.
30. HILL, D.J., STRAIN, A.J. & MILNER, R.D.G. (1986b). Presence of transforming growth factor-fl-like activity in multiple fetal rat tissues. Cell Biol. Int. Rep., 10, 915.
31. IGNOTZ, R. & MASSAGUE, J. (1986). Transforming growth factor-fl stimulates the expression of fibronectin and collagen into the extracellular matrix. J. Biol. Chem. 261, 4337.
32. IGNOTZ, R.A., ENDO, T. & MASSAGUE, J. (1987). Regulation of fibronectin and type 1 collagen mRNA levels by transforming growth factor-fl. J. Biol. Chem., 262, 6443.
33. IGNOTZ, R.A. & MASSAGUE, J. (1987). Cell adhesion protein receptors as targets for transforming growth factor-fl action. Cell, 51, 189.
34. JOHNSSON, A., BETSHOLTZ, C., HELDIN, C.-H. & WESTERMARK, B. (1985). Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus. Nature, 317, 438.
35. KEHRL, J.H., ROBERTS, A.B., WAKEFIELD, L.M., JAKOWLEW, S.B., SPORN, M.B. & FAUCI, A.S. (1986a). Transforming growth factor fi is an important immunomodulatory protein for human Blymphocytes. J. Immunol., 137, 3855.
36. KEHRL, J.H., WAKEFIELD, L.M., ROBERTS, A.B. & 5 others (1986b). Production of transforming growth factor fi by human T lymphocytes and its potential role in the regulation of T cell growth. J1. Exp. Med., 163, 1037.
37. KIMELMAN, D. & KIRSCHNER, M. (1987). Synergistic induction of mesoderm by FGF and TGF-fl and the identification of an mRNA coding for FGF in the early xenopus embryo. Cell, 51, 869.
38. LAIHO, M., SAKESELA, O., ANDREASEN, P.A. & KESKI-OJA, J. (1986). Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-P. J. Cell Biol., 103, 2403.
39. LAWRENCE, D.A., PIRCHER, R. & JULLIEN, P. (1985). Conversion of a high molecular weight latent f-TGF from chicken embryo fibroblasts into a low molecular weight active f-TGF under acidic conditions. Biochem. Biophys. Res. Commun., 133, 1026.
40. LECHNER, J.F., McCLENDON, I.A., LAVECK, M.A., SHAMSUDDIN, A.M. & HARRIS, C.C. (1983). Differential control by platelet factors of squamous differentiation in normal and malignant bronchial epithelial cells. Cancer Res., 43, 5915.
41. LING, N., YING, S.-Y., UENO, N. & 4 others (1986). Pituitary FSH is released by a heterodimer of the fl-subunits from the two forms of inhibin. Nature, 321, 779.
42. MADRI, J.A., PRATT, B.M. & TUCKER, A. (1988). Phenotypic modulation of endothelial cells by transforming growth factor-fl depends upon the composition and organization of the extracellular matrix. J. Cell. Biol. (in press).
43. MARQUARDT, H., LIOUBIN, M.N. & IKEDA, T. (1987). Complete amino acid sequence of human transforming growth factor type f2. J. Biol. Chem., 262, 12127.
44. MASON, A.J., HAYFLICK, J.S., LING, N. & 6 others (1985). Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-#. Nature, 318, 659.
45. MATRISIAN, L.M., LEROY, P., RUHLMANN, C., GESNEL, M.-C. & BREATHNACH, R. (1986). Isolation of the oncogene and epidermal growth factor-induced transin gene: Complex control in rat fibroblasts. Molec. Cell. Biol., 6, 1679.
46. McMAHON, J.B., RICHARDS, W.L., DEL CAMPO, A.A., SONG, M.-K.H. & THORGEIRSSON, S.S. (1986). Differential effects of transforming growth factor-fl on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res., 46, 4665.
47. MOSES, H.L., TUCKER, R.F., LEOF, E.B., COFFEY, R.J., HALPER, J. & SHIPLEY, G.D. (1985). Type fi transforming growth factor is a growth stimulator and a growth inhibitor. In Cancer Cells; 3, Feramisco, J. (ed) p. 65. Cold Spring Harbor Laboratory.
48. MULE, J.J., SCHWARZ, S.L., ROBERTS, A.B., SPORN, M.B. & ROSENBERG, S.A. (1988). Transforming growth factor-fl inhibits the in vitro generation of lymphokine activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. (in press).
49. OHTA, M., GREENBERGER, J.S., ANKLESARIA, P., BASSOLS, A. & MASSAGUE, J. (1987). Two forms of transforming growth factorfi distinguished by multipotential haematopoietic progenitor cells. Nature, 329, 539.
50. PADGETT, R.W., ST JOHNSTON, R.D. & GELBART, W.M. (1987). A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-# family. Nature, 325, 81.
51. PROPER, J.A., BJORNSON, C.L. & MOSES, H.L. (1982). Mouse embryos contain polypeptide growth factors capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture. J. Cell. Physiol., 110, 169.
52. POSTLETHWAITE, A.E., KESKI-OJA, J., MOSES, H.L. & KANG, A.H. (1987). Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor fi. J. Exp. Med., 165, 251.
53. RANGES, G.E., FIGARI, I.S., ESPEVIK, T. & PALLADINO, M.A. (1987). Inhibition of cytotoxic T cell development bt transforming growth factor fi and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med., 166, 991.
54. ROBERTS, A.B., ANZANO, M.A., MEYERS, C.A. & 8 others (1983). Purification and properties of a type P transforming growth factor from bovine kidney. Biochemistry, 22, 5692.
55. ROBERTS, A.B., FLANDERS, K.C., KONDAIAH, P. & 7 others (1988). Transforming growth factor fi: Biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Progress in Horm. Res. (in press).
56. ROBERTS, A.B., SPORN, M.B., ASSOIAN, R.K., SMITH, J.M. & 7 others (1986). Transforming growth factor type-fl: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA, 83, 4167.
57. ROBERTS, A.B., ANZANO, M.A., WAKEFIELD, L.M., ROCHE, N.S., STERN, D.F. & SPORN, M.B. (1985). Type fi transforming growth factor: A bifunctional regulator of cellular growth. Proc. Natl Acad. Sci. USA, 82, 119.
58. ROBEY, P.G., YOUNG, M.F., FLANDERS, K.C. & 6 others (1987). Osteoblasts synthesize and respond to TGF-, B in vitro. J. Cell Biol., 105, 457.
59. ROOK, A.H., KEHRL, J.H., WAKEFIELD, L.M., (1986). Effects of transforming growth factor, B on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol., 136, 3916.
60. ROSA, F., ROBERTS, A.B., DANIELPOUR, D., DART, L.L., SPORN, M.B. & DAWID, I.B. (1988). Mesoderm induction in amphibians: The role of TGF-, B2-like factors. Science, (in press).
61. ROSSI, P., KARSENTY, G., ROBERTS, A.B., ROCHE, N.S., SPORN, M.B. & DE CROMBRUGGHE, B. (1988). A nuclear factor 1 binding site mediates the transcriptional activation of a type 1 collagen promoter by transforming growth factor /B. Cell (in press).
62. SEGARINI, P.R., ROBERTS, A.B., ROSEN, D.M. & SEYEDIN, S.M. (1987). Membrane binding characteristics of two forms of transforming growth factor-, B. J. Biol. Chem., 262, 14655.
63. SEYEDIN, S.M., THOMAS, T.C., THOMPSON, A.Y., ROSEN, D.M. & PIEZ, K.A. (1985). Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc. Natl Acad. Sci. USA, 82, 2267.
64. SHIPLEY, G.D., PITTELKOW, M.R., WILLE, J.J., SCOTT, R.E. & MOSES, H.L. (1986). Reversible inhibition of normal human prokeratinocyte proliferation by type, B transforming growth factor-growth inhibitor in serum-free medium. Cancer Res., 46, 2068.
65. SPORN, M.B. & ROBERTS, A.B. (1985). Autocrine growth factors and cancer. Nature, 313, 747.
66. SPORN, M.B., ROBERTS, A.B., WAKEFIELD, L.M. & DE CROMBRUGGHE, B. (1987). Some recent advances in the chemistry and biology of transforming growth factor-, B. J. Cell Biol., 105, 1039.
67. SPORN, M.B. & ROBERTS, A.B. (1986). Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest., 78, 329.
68. SPORN, M.B. & ROBERTS, A.B. (1988a). Transforming growth factor- #: New chemical forms and new biological roles. Biofactors (in press).
69. SPORN, M.B. & ROBERTS, A.B. (1988b). Peptide growth factors are multifunctional. Nature (submitted).
70. TUCKER, R.F., SHIPLEY, G.D., MOSES, H.L. & HOLLEY, R.W. (1984). Growth inhibitor from BSC-1 cells closely related to platelet type, B transforming growth factor. Science, 226, 705.
71. VALE, W., RIVIER, J., VAUGHAN, J. & 5 others (1986). Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature, 321, 776.
72. WAHL, S.M., HUNT, D.A., WAKEFIELD, L.M. & 4 others (1987). Transforming growth-factor, B (TGF-, B) induces monocyte chemotaxis and growth factor production. Proc. Natl Acad. Sci. USA, 84, 5788.
73. WAKEFIELD, L.M., SMITH, D.M., FLANDERS, K.C. & SPORN, M.B. (1987a). Characterization of a latent form of transforming growth factor-fl secreted by human platelets. J. Cell. Biochem. Suppl., 11A, 46.
74. WAKEFIELD, L.M., SMITH, D.M., MASUI, T., HARRIS, C.C. & SPORN, M.B. (1987b). Distribution and modulation of the cellular receptor for transforming growth factor-#. J. Cell. Biol., 105, 965.
75. WEEKS, D.L. & MELTON, D.A. (1987). A maternal mRNA localized to the vegetal hemisphere in xenopus eggs codes for a growth factor related to TGF-fl. Cell, 51, 861.
76. WIGLEY, C.B., PARASKEVA, C. & COVENTRY, R. (1986). Elevated production of growth factor by human premalignant colon adenomas and a derived epithelial cell line. Br. J. Cancer, 54, 779.
77. WOLLENBERG, G.K., SEMPLE, E., QUINN, B.A. & HAYES, M.A. (1987). Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-fl. Cancer Res., 47, 6595.
78. WRANN, M., BODMER, S., DE MARTIN, R. & 5 others (1987). T cell suppressor factor from human glioblastoma cells is a 12.5 KD protein closely related to transforming growth factor-fl. EMBO J., 6, 1633.